FRIDAY, Oct. 25, 2024 -- Cognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue,...
Vous n'êtes pas connecté
New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study, presented
FRIDAY, Oct. 25, 2024 -- Cognitive behavioral therapy (CBT), modafinil, and their combination are equally beneficial for multiple sclerosis fatigue,...
The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years after treatment ends.
MONDAY, Oct. 28, 2024 -- Smoking marijuana during pregnancy may quell your morning sickness, but it could also harm your child’s development, a...
Agroundbreaking” drug is currently being trialed in the first British patients to treat autoimmune conditions like lupus and multiple sclerosis....
A new study from the MD Anderson Cancer Center reveals that quitting smoking within six months of a cancer diagnosis can significantly improve...
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a ‘magic bullet’ strategy that combines the...
The detailed study results confirmed interim findings, showing stable kidney function and sustained treatment effect more than 18 months after the...
THURSDAY, Oct. 31, 2024 -- Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in...
THURSDAY, Nov. 7, 2024 -- Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new...
A new study by Concordia researchers suggests that one-third of adult survivors of childhood cancer experience a fear of cancer recurrence so severe...